MENU
MLYS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Mineralys Therapeutics (MLYS) Ownership - Who owns Mineralys Therapeutics?
Profile
Industry
N/A
Address
150 North Radnor Chester Road
Phone
+1 888 378-6240
Employees
28
Web
https://mineralystx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
613.65M
P/E Ratio
N/A
Total Cash
263.6M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
5.30
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
MLYS
Capitalization
614M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
264M
Total Cash/Share
5.30
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
237M
P/B Ratio
2.59
Cash Flow
N/A
Earnings
-3.31
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
8.55
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-168.35M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-56.16
Shares Held By Institutions
677M
Shares Outstanding - Current
49.8M
Total Liabilities
31.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
43.488
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
150 North Radnor Chester Road
Phone
+1 888 378-6240
Employees
28
Web
https://mineralystx.com